We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Sequenom Laboratories Announces Positive Results from Clinical Validation Study on the Maternit® Genome Test

News   Mar 01, 2016

 
Sequenom Laboratories Announces Positive Results from Clinical Validation Study on the Maternit® Genome Test
 
 
 

RELATED ARTICLES

Human Cell Atlas Study Sheds Light on Maternal-Fetal Interface

News

The first Human Cell Atlas study of early pregnancy in humans has shown how the function of the maternal immune system is affected by cells from the developing placenta.

READ MORE

Determining the Likelihood of Long-term Brain Damage in Newborns

News

A 15-minute scan could help diagnose brain damage in babies up to two years earlier than current methods.

READ MORE

Researchers Identify Mechanism That Fuels Cancer Cells’ Growth

News

Scientists have identified sodium glucose transporter 2 (SGLT2) as a mechanism that lung cancer cells can utilize to obtain glucose, which is key to their survival and promotes tumor growth. The finding provides evidence that SGLT2 may be a novel biomarker that scientists can use to help diagnose precancerous lung lesions and early-stage lung cancers.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE